 |
 |
|
 |
Sosei Group has a broad product pipeline which has been primarily established through in-licensing and in-house product discovery which comprises two elements.
 |
 |
 |
| In-licensing: In-licensing
Japan rights for established or late-stage development products.
|
|
 |
 |
 |
 |
- new uses for marketed drugs and marketed drug templates and
- new uses for drugs that have stalled in development.
|
|
 |
 |
 |
 |